Cannabis, or Marijuana is a controlled substance which is illegal to possess, use, or distribute in New York State. Medical Marijuana, however, is legal in New York State although adult recreational use remains prohibitied. Under the federal Controlled Substances Act of 1970, marijuana was placed in Schedule I, which defines the substance as having a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision.
Jacobowitz and Gubits attorneys are ready to help New York businesses entering the cannabis industry by providing legal direction in the areas of:
- Government Regulations and Compliance
- Licensing and Permitting
- New York State Licensing for Cultivation and Dispensaries
- Business Counseling and Litigation
- Intellectual Property – Trademarks and Copywriting
- Labor and Employment
- Real Estate
- Land Use and Zoning
- ADA Compliance
- Tax Advice
Many of our attorneys have received the necessary continuing educational training to provide you with the guidance necessary to follow the federal and state laws governing cannabis law.
Governor Cuomo Actions
In January 2018, Governor Cuomo called for an assessment of the possible impact of regulating marijuana in New York State. NYS agencies evaluated the health, public safety, and economic impact of legalizing marijuana. A summary of the report has been provided by Robert M. Lefland and you can view it here. This 74-page assessment concludes that the benefits of legalization outweigh potential risks. It suggests that NYS could raise nearly $700 million in tax revenue from this drug and that legalization won’t significantly increase rates of marijuana use by adults and teens. The report suggests that legalizing marijuana could both reduce opioid dependency while eliminating criminal penalties that disproportionately impact minorities. This report was released in July, 2018.
In August, Governor Cuomo took another step toward legalizing marijuana in New York State, announcing the formation of a 20-person work group to draft legislation allowing for recreational use by adults.
Marijuana in New York State
Staying current is important in all areas of law. The legal use of marijuana in New York State is undergoing intense scrutiny and much is changing. There is, however, one aspect which remains crystal clear, if not subject to change at almost any moment.
The recreational use of marijuana, as of this writing August 10, 2018, remains illegal.
Medical use, however, has changed. In July 2014, Governor Andrew M. Cuomo and the New York State Legislature enacted the Compassionate Care Act to provide a comprehensive, safe and effective medical marijuana program that meets the needs of New Yorkers. This bill comprehensively regulates the manufacture, sale and use of medical marijuana. It attempts to strike the right balance between potentially relieving the pain and suffering of those in desperate need of a treatment and protecting the public against risks to its health and safety. The balance is maintained by granting discretion to physicians to prescribe in accordance with regulatory requirements and medical norms, empowering the Department of Health to oversee the regimen of medical marijuana usage and leaving to the Governor, the final say in seeing that the public’s safety and health are protected by authorizing him to discontinue the program, in whole or in part, should risks to the public so warrant.
Department of Health
The Department of Health has stated that as of July 10, 2018, there are 62,256 certified patients and 1,735 registered practitioners participating in the program.
On December 8, 2017 The New York State Department of Health announced that it was filing regulations for adoption that will improve the state’s Medical Marijuana Program for patients, practitioners and registered organizations. These regulations, which went into effect on December 27, 2017, allow for the sale of additional medical marijuana products, an improved experience for patients and visitors at dispensing facilities and the ability for the Department to approve new courses that will allow prospective practitioners to complete their training in a shorter amount of time.
Under the new regulations, registered organizations (ROs) are allowed to manufacture and distribute additional products including topicals such as ointments, lotions and patches; solid and semi-solid products, including chewable and effervescent tablets and lozenges; and certain non-smokable forms of ground plant material. All products are subject to rigorous testing, and the Department reserves the right to exclude inappropriate products or those which pose a threat to public health.
Other recent enhancements to New York’s Medical Marijuana Program include authorizing five additional registered organizations to manufacture and dispense medical marijuana, adding post-traumatic stress disorder and chronic pain as qualifying conditions, empowering nurse practitioners and physician assistants to certify patients and permitting home delivery.